TNFRSF9 and autoimmune disease: This strong ability of anti-4-1BB to amplify CD8+ T cells in vivo has emerged as a valuable therapeutic tool to counter bacterial and viral infection, cancer, transplant rejection, graft-versus-host disease, and autoimmune disease [2], [3], [7], [8].